ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced the initiation of SERENE, a Phase II study with pimavanserin for the treatment of...

What are the 5 Top Holdings in the SPDR S&P Biotechnology ETF?

Which companies have the heaviest weight in the SPDR S&P Biotechnology ETF

5 Top NASDAQ Biotech Stocks: 5 Companies Gain over 30 Percent Last Week

Gaining over 30 percent for the week were ACADIA Pharmaceuticals, Galena Biopharma, Hasen Medical , Cardiovascular Systems, and Vivus Inc